This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the forecast period. Insulin and oral anti-diabetic drugs are covered in detail, with market size and forecasting. Clinical trials in India for new classes of drugs for diabetes management are also covered.
Disclaimer and Table of Contents
- Disclaimer
- Certification
- Table of Contents
- List of Figures
- List of Charts
Research Objectives and Approach
- Research Objectives
- Research Approach
Prevalence and Incidence of Diabetes in India
- Global Diabetes Therapeutic Market and Its Prevalence
- Snapshot of Diabetes Prevalence in India
- Prevalence of Diabetes: India
Treatment Challenges
- Key Treatment Challenges
Market Engineering Measurements
- Market Engineering Measurements - India
Market Assessment
- Market Drivers
- Market Restraints
- Revenue Forecast
- Market Size - Oral Anti-Diabetics and Insulin Segments
Market Assessment: Patient Share Forecast
- Overview: Estimated Patient Share Forecasts by Type of Treatment
- Patient Share Forecast by Treatment
Future Trends
- Key Treaters
- Future Trends in Diabetes Management
Appendix
- Therapies in the Treatment of Diabetes
- Competitive Landscape: Key Multinational Participants
- Competitive Landscape: Key Domestic Participants
- Clinical Trials: Summary
- Clinical Trials: India
Decision Support Databases
- Decision Support Databases
About Frost & Sullivan
- About Frost & Sullivan
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the forecast period. Insulin and oral anti-diabetic drugs are covered in detail, with market size and forecasting. Clinical trials in India for new classes of drugs for diabetes management are also covered.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Dipak Mahajan |
| Industries | Healthcare |
| WIP Number | P585-01-00-00-00 |
| Is Prebook | No |
Overview of the Diabetes Therapeutics Market in India
Overview of the Diabetes Therapeutics Market in India
Diabetes, an Apparent Epidemic in India: Opportunities for Pharmaceutical Companies
RELEASE DATE
03-Oct-2012
03-Oct-2012
REGION
South Asia, Middle East & North Africa
South Asia, Middle East & North Africa
Deliverable Type
Market Research
Market Research
Research Code: P585-01-00-00-00
SKU: HC02360-SA-MR_08449
$4,950.00
In stock
SKU
HC02360-SA-MR_08449